Inreda Diabetic appoints Chief Commercial Officer

May 31, 2024, Goor – Inreda® Diabetic is delighted to announce the appointment of Colin Wensveen as Chief Commercial Officer, effective June 1st, 2024. With 10 years of experience in the field of diabetes in the Netherlands and various other European countries, Colin brings a wealth of experience and expertise to Inreda’s rapidly growing team.

Over the past few years, Colin has proven to be strategically and operationally successful in various leadership roles in marketing, sales, and business development. Prior to joining Inreda®, he worked at Mediq as Commercial Director Diabetes, where he was responsible for the international diabetes strategy.

As Chief Commercial Officer, Colin will focus on strengthening Inreda’s commercial strategy and preparing for the European market introduction of the Inreda AP®. His ability to build strong relationships and achieve profitable growth aligns perfectly with Inreda’s ambitious goals.